Literature DB >> 17021114

Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping.

Ted E Schutzbank1, Susan E Sefers, Nicole Kahmann, Haijing Li, Yi-Wei Tang.   

Abstract

We compared the performances of three hepatitis C virus genotyping methodologies supplied by Bayer, Abbott, and Third Wave Technologies. Genotypes were determined for 136 of 137 specimens by the Bayer method, 121 of 137 specimens by the Invader assay, and only 77 of 137 specimens by the Abbott assay. All reported genotypes were concordant by all three methods.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17021114      PMCID： PMC1594808          DOI： 10.1128/JCM.01159-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

Review 1.  Laboratory assays for diagnosis and management of hepatitis C virus infection.

Authors:  Sandra S Richter
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Primer sequence modification enhances hepatitis C virus genotype coverage.

Authors:  Yi-Wei Tang; Susan E Sefers; Haijing Li
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a.

Authors:  S Zeuzem; E Herrmann; J H Lee; J Fricke; A U Neumann; M Modi; G Colucci; W K Roth
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

Review 4.  Hepatitis C virus kinetics.

Authors:  E Herrmann; A U Neumann; J M Schmidt; S Zeuzem
Journal:  Antivir Ther       Date:  2000-06

5.  Second-generation line probe assay for hepatitis C virus genotyping.

Authors:  L Stuyver; A Wyseur; W van Arnhem; F Hernandez; G Maertens
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Evaluation of the invader assay for genotyping hepatitis C virus.

Authors:  Jeffrey J Germer; David W Majewski; Billy Yung; P Shawn Mitchell; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline.

Authors:  Jennifer E Layden; Thomas J Layden; K Rajender Reddy; Rachel S Levy-Drummer; Jennifer Poulakos; Avidan U Neumann
Journal:  J Viral Hepat       Date:  2002-09       Impact factor: 3.728

8.  Detection of hepatitis C virus by a user-developed reverse transcriptase-PCR and use of amplification products for subsequent genotyping.

Authors:  Yi-Wei Tang; Haijing Li; Ann Roberto; Diane Warner; Belinda Yen-Lieberman
Journal:  J Clin Virol       Date:  2004-10       Impact factor: 3.168

9.  Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region.

Authors:  Frederick S Nolte; Alicia M Green; Kristin R Fiebelkorn; Angela M Caliendo; Cynthia Sturchio; Aileen Grunwald; Mimi Healy
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

10.  Evaluation of the TRUGENE HCV 5'NC genotyping kit with the new GeneLibrarian module 3.1.2 for genotyping of hepatitis C virus from clinical specimens.

Authors:  Jeffrey J Germer; David W Majewski; Michael Rosser; Amber Thompson; P Shawn Mitchell; Thomas F Smith; Slava Elagin; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948
  10 in total
  1 in total

1.  Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses.

Authors:  Maria A Bracho; Verónica Saludes; Elisa Martró; Ana Bargalló; Fernando González-Candelas; Vicent Ausina
Journal:  Virol J       Date:  2008-06-05       Impact factor: 4.099
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.